The Ability of Carnitine to Act as a Type 1Histone Deacetylase Inhibitor May Explain the Favorable Impact of Carnitine Supplementation on Mitochondrial Biogenesis in the Elderly

Main Article Content

Mark McCarty James J. DiNicolantonio James H. O'Keefe


A number of studies have shown that carnitine supplementation – alone or in conjunction with supplemental lipoic acid - promotes mitochondrial biogenesis (MB) in skeletal, muscle, and brain of aging rodents; no such effect is seen in younger animals.  These findings parallel clinical studies in which supplemental carnitine improves physical and mental energy in elderly humans, while decreasing body fat and increasing lean mass – effects that have not been achieved with carnitine in younger people.  The age dependence of these phenomena appears to reflect the fact that tissue carnitine levels, especially those in muscle, decline during aging; carnitine supplementation restores higher, more youthful tissues carnitine levels in aging animals, but has relatively little impact in this regard on younger ones.  The effect of supplemental carnitine on MB in aging animals appears to be mediated, in whole or in part, by increased expression of PPARγ-coactivator-1α (PGC-1α), a key driver of MB.  There is recent evidence that, in low millimolar intracellular concentrations such as those seen in skeletal muscle, carnitine functions as an inhibitor of type 1 histone deacetylases (HDACs).  Moreover, it has been reported that drug inhibitors of these deacetylases boost mRNA and protein expression of PGC-1α, presumably by promoting transcription of the PGC-1a gene; these drugs also amplify MB.  It is therefore proposed that intracellular carnitine provides a moderate tonic inhibition of type 1 HDACs that supports PGC1α transcription and that diminishes with age as tissue carnitine levels decline; hence, carnitine supplementation in the elderly restores youthful expression of PGC-1α and promotes MB.  The complementary impact of lipoic acid on MB may reflect the fact that the promoter of the gene coding for nuclear respiratory factor-1 (NRF-1) contains antioxidant response elements; hence, NRF-1 transcription is promoted by phase 2 inducers such as lipoic acid.  PGC-1α and NRF-1 collaborate in driving the expression of mitochondrial proteins.  Additional nutraceutical measures which may likewise support MB – citrulline, taurine, N-acetylcysteine, high-dose biotin, and astaxanthin – are discussed. The adverse impact of metabolic syndrome on MB in skeletal muscle may be mediated by toll-like receptor 4 (TLR4) signaling stimulated by saturated fatty acids; antagonists of TLR4 signaling, possibly including ferulic acid and phycocyanobilin, may therefore promote MB in the context of metabolic syndrome.  Restoration of youthful MB in the elderly may have favorable impacts on physical capacity and cognitive function, body composition, insulin sensitivity, and oxidative stress.

Article Details

How to Cite
MCCARTY, Mark; DINICOLANTONIO, James J.; O'KEEFE, James H.. The Ability of Carnitine to Act as a Type 1Histone Deacetylase Inhibitor May Explain the Favorable Impact of Carnitine Supplementation on Mitochondrial Biogenesis in the Elderly. Medical Research Archives, [S.l.], v. 8, n. 2, feb. 2020. ISSN 2375-1924. Available at: <>. Date accessed: 04 apr. 2020. doi:
Research Articles


(1) Costell M, O'Connor JE, Grisolia S. Age-dependent decrease of carnitine content in muscle of mice and humans. Biochem Biophys Res Commun 1989 June 30;161(3):1135-43.
(2) Costell M, Grisolia S. Effect of carnitine feeding on the levels of heart and skeletal muscle carnitine of elderly mice. FEBS Lett 1993 January 2;315(1):43-6.
(3) Karlic H, Lohninger A, Laschan C et al. Downregulation of carnitine acyltransferases and organic cation transporter OCTN2 in mononuclear cells in healthy elderly and patients with myelodysplastic syndromes. J Mol Med (Berl) 2003 July;81(7):435-42.
(4) Tamai I, Ohashi R, Nezu J et al. Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J Biol Chem 1998 August 7;273(32):20378-82.
(5) Tanaka Y, Sasaki R, Fukui F et al. Acetyl-L-carnitine supplementation restores decreased tissue carnitine levels and impaired lipid metabolism in aged rats. J Lipid Res 2004 April;45(4):729-35.
(6) Wall BT, Stephens FB, Constantin-Teodosiu D, Marimuthu K, Macdonald IA, Greenhaff PL. Chronic oral ingestion of L-carnitine and carbohydrate increases muscle carnitine content and alters muscle fuel metabolism during exercise in humans. J Physiol 2011 February 15;589(Pt 4):963-73.
(7) Gadaleta MN, Petruzzella V, Renis M, Fracasso F, Cantatore P. Reduced transcription of mitochondrial DNA in the senescent rat. Tissue dependence and effect of L-carnitine. Eur J Biochem 1990 February 14;187(3):501-6.
(8) Pesce V, Fracasso F, Cassano P, Lezza AM, Cantatore P, Gadaleta MN. Acetyl-L-carnitine supplementation to old rats partially reverts the age-related mitochondrial decay of soleus muscle by activating peroxisome proliferator-activated receptor gamma coactivator-1alpha-dependent mitochondrial biogenesis. Rejuvenation Res 2010 April;13(2-3):148-51.
(9) Pesce V, Nicassio L, Fracasso F, Musicco C, Cantatore P, Gadaleta MN. Acetyl-L-carnitine activates the peroxisome proliferator-activated receptor-gamma coactivators PGC-1alpha/PGC-1beta-dependent signaling cascade of mitochondrial biogenesis and decreases the oxidized peroxiredoxins content in old rat liver. Rejuvenation Res 2012 April;15(2):136-9.
(10) Nicassio L, Fracasso F, Sirago G et al. Dietary supplementation with acetyl-l-carnitine counteracts age-related alterations of mitochondrial biogenesis, dynamics and antioxidant defenses in brain of old rats. Exp Gerontol 2017 November;98:99-109.
(11) Rosca MG, Lemieux H, Hoppel CL. Mitochondria in the elderly: Is acetylcarnitine a rejuvenator? Adv Drug Deliv Rev 2009 November 30;61(14):1332-42.
(12) Fernandez-Marcos PJ, Auwerx J. Regulation of PGC-1alpha, a nodal regulator of mitochondrial biogenesis. Am J Clin Nutr 2011 April;93(4):884S-90.
(13) Huang H, Liu N, Guo H et al. L-carnitine is an endogenous HDAC inhibitor selectively inhibiting cancer cell growth in vivo and in vitro. PLoS One 2012;7(11):e49062.
(14) Huang H, Liu N, Yang C et al. HDAC inhibitor L-carnitine and proteasome inhibitor bortezomib synergistically exert anti-tumor activity in vitro and in vivo. PLoS One 2012;7(12):e52576.
(15) Galmozzi A, Mitro N, Ferrari A et al. Inhibition of class I histone deacetylases unveils a mitochondrial signature and enhances oxidative metabolism in skeletal muscle and adipose tissue. Diabetes 2013 March;62(3):732-42.
(16) Pistone G, Marino A, Leotta C, Dell'Arte S, Finocchiaro G, Malaguarnera M. Levocarnitine administration in elderly subjects with rapid muscle fatigue: effect on body composition, lipid profile and fatigue. Drugs Aging 2003;20(10):761-7.
(17) Malaguarnera M, Di MA, Gargante PM, Rampello L. L-carnitine reduces severity of physical and mental fatigue and improves daily activities in the elderly. South Med J 2006 March;99(3):315-6.
(18) Malaguarnera M, Cammalleri L, Gargante MP, Vacante M, Colonna V, Motta M. L-Carnitine treatment reduces severity of physical and mental fatigue and increases cognitive functions in centenarians: a randomized and controlled clinical trial. Am J Clin Nutr 2007 December;86(6):1738-44.
(19) Badrasawi M, Shahar S, Zahara AM, Nor FR, Singh DK. Efficacy of L-carnitine supplementation on frailty status and its biomarkers, nutritional status, and physical and cognitive function among prefrail older adults: a double-blind, randomized, placebo-controlled clinical trial. Clin Interv Aging 2016;11:1675-86.
(20) Vandenbeek R, Khan NP, Estall JL. Linking Metabolic Disease With the PGC-1alpha Gly482Ser Polymorphism. Endocrinology 2018 February 1;159(2):853-65.
(21) Lee HK, Song JH, Shin CS et al. Decreased mitochondrial DNA content in peripheral blood precedes the development of non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 1998 December;42(3):161-7.
(22) Park KS, Lee KU, Song JH et al. Peripheral blood mitochondrial DNA content is inversely correlated with insulin secretion during hyperglycemic clamp studies in healthy young men. Diabetes Res Clin Pract 2001 May;52(2):97-102.
(23) Park KS, Song JH, Lee KU et al. Peripheral blood mitochondrial DNA content correlates with lipid oxidation rate during euglycemic clamps in healthy young men. Diabetes Res Clin Pract 1999 November;46(2):149-54.
(24) Liu J, Head E, Gharib AM et al. Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: partial reversal by feeding acetyl-L-carnitine and/or R-alpha -lipoic acid. Proc Natl Acad Sci U S A 2002 February 19;99(4):2356-61.
(25) Hagen TM, Moreau R, Suh JH, Visioli F. Mitochondrial decay in the aging rat heart: evidence for improvement by dietary supplementation with acetyl-L-carnitine and/or lipoic acid. Ann N Y Acad Sci 2002 April;959:491-507.
(26) Shen W, Liu K, Tian C et al. R-alpha-lipoic acid and acetyl-L-carnitine complementarily promote mitochondrial biogenesis in murine 3T3-L1 adipocytes. Diabetologia 2008 January;51(1):165-74.
(27) Long J, Gao F, Tong L, Cotman CW, Ames BN, Liu J. Mitochondrial decay in the brains of old rats: ameliorating effect of alpha-lipoic acid and acetyl-L-carnitine. Neurochem Res 2009 April;34(4):755-63.
(28) Zhang H, Jia H, Liu J et al. Combined R-alpha-lipoic acid and acetyl-L-carnitine exerts efficient preventative effects in a cellular model of Parkinson's disease. J Cell Mol Med 2010 January;14(1-2):215-25.
(29) Suh JH, Shenvi SV, Dixon BM et al. Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid. Proc Natl Acad Sci U S A 2004 March 9;101(10):3381-6.
(30) Ogborne RM, Rushworth SA, O'Connell MA. Alpha-lipoic acid-induced heme oxygenase-1 expression is mediated by nuclear factor erythroid 2-related factor 2 and p38 mitogen-activated protein kinase in human monocytic cells. Arterioscler Thromb Vasc Biol 2005 October;25(10):2100-5.
(31) Shay KP, Michels AJ, Li W, Kong AN, Hagen TM. Cap-independent Nrf2 translation is part of a lipoic acid-stimulated detoxification stress response. Biochim Biophys Acta 2012 June;1823(6):1102-9.
(32) Piantadosi CA, Carraway MS, Babiker A, Suliman HB. Heme oxygenase-1 regulates cardiac mitochondrial biogenesis via Nrf2-mediated transcriptional control of nuclear respiratory factor-1. Circ Res 2008 November 21;103(11):1232-40.
(33) Piantadosi CA, Withers CM, Bartz RR et al. Heme oxygenase-1 couples activation of mitochondrial biogenesis to anti-inflammatory cytokine expression. J Biol Chem 2011 May 6;286(18):16374-85.
(34) Perez-Ternero C, Werner CM, Nickel AG et al. Ferulic acid, a bioactive component of rice bran, improves oxidative stress and mitochondrial biogenesis and dynamics in mice and in human mononuclear cells. J Nutr Biochem 2017 October;48:51-61.
(35) Denzer I, Munch G, Friedland K. Modulation of mitochondrial dysfunction in neurodegenerative diseases via activation of nuclear factor erythroid-2-related factor 2 by food-derived compounds. Pharmacol Res 2016 January;103:80-94.
(36) Negrette-Guzman M, Huerta-Yepez S, Vega MI et al. Sulforaphane induces differential modulation of mitochondrial biogenesis and dynamics in normal cells and tumor cells. Food Chem Toxicol 2017 February;100:90-102.
(37) Fernandez-Marcos PJ, Auwerx J. Regulation of PGC-1alpha, a nodal regulator of mitochondrial biogenesis. Am J Clin Nutr 2011 April;93(4):884S-90.
(38) Suwa M, Nakano H, Kumagai S. Effects of chronic AICAR treatment on fiber composition, enzyme activity, UCP3, and PGC-1 in rat muscles. J Appl Physiol (1985 ) 2003 September;95(3):960-8.
(39) Irrcher I, Ljubicic V, Kirwan AF, Hood DA. AMP-activated protein kinase-regulated activation of the PGC-1alpha promoter in skeletal muscle cells. PLoS One 2008;3(10):e3614.
(40) Settembre C, De CR, Mansueto G et al. TFEB controls cellular lipid metabolism through a starvation-induced autoregulatory loop. Nat Cell Biol 2013 June;15(6):647-58.
(41) Kim SH, Kim G, Han DH et al. Ezetimibe ameliorates steatohepatitis via AMP activated protein kinase-TFEB-mediated activation of autophagy and NLRP3 inflammasome inhibition. Autophagy 2017 October 3;13(10):1767-81.
(42) Akimoto T, Pohnert SC, Li P et al. Exercise stimulates Pgc-1alpha transcription in skeletal muscle through activation of the p38 MAPK pathway. J Biol Chem 2005 May 20;280(20):19587-93.
(43) Zhao M, New L, Kravchenko VV et al. Regulation of the MEF2 family of transcription factors by p38. Mol Cell Biol 1999 January;19(1):21-30.
(44) Henriquez-Olguin C, Diaz-Vegas A, Utreras-Mendoza Y et al. NOX2 Inhibition Impairs Early Muscle Gene Expression Induced by a Single Exercise Bout. Front Physiol 2016;7:282.
(45) Handschin C, Rhee J, Lin J, Tarr PT, Spiegelman BM. An autoregulatory loop controls peroxisome proliferator-activated receptor gamma coactivator 1alpha expression in muscle. Proc Natl Acad Sci U S A 2003 June 10;100(12):7111-6.
(46) Fulco M, Cen Y, Zhao P et al. Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. Dev Cell 2008 May;14(5):661-73.
(47) Canto C, Gerhart-Hines Z, Feige JN et al. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 2009 April 23;458(7241):1056-60.
(48) Lan F, Cacicedo JM, Ruderman N, Ido Y. SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation. J Biol Chem 2008 October 10;283(41):27628-35.
(49) Ruderman NB, Xu XJ, Nelson L et al. AMPK and SIRT1: a long-standing partnership? Am J Physiol Endocrinol Metab 2010 April;298(4):E751-E760.
(50) Xu HG, Zhai YX, Chen J et al. LKB1 reduces ROS-mediated cell damage via activation of p38. Oncogene 2015 July;34(29):3848-59.
(51) Zhou G, Myers R, Li Y et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001 October;108(8):1167-74.
(52) Musi N, Hirshman MF, Nygren J et al. Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. Diabetes 2002 July;51(7):2074-81.
(53) Lee YS, Kim WS, Kim KH et al. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes 2006 August;55(8):2256-64.
(54) Owen MR, Doran E, Halestrap AP. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J 2000 June 15;348 Pt 3:607-14.
(55) Hawley SA, Ross FA, Chevtzoff C et al. Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation. Cell Metab 2010 June 9;11(6):554-65.
(56) Turner N, Li JY, Gosby A et al. Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action. Diabetes 2008 May;57(5):1414-8.
(57) Nisoli E, Clementi E, Paolucci C et al. Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science 2003 February 7;299(5608):896-9.
(58) Nisoli E, Falcone S, Tonello C et al. Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals. Proc Natl Acad Sci U S A 2004 November 23;101(47):16507-12.
(59) Haas B, Mayer P, Jennissen K et al. Protein kinase G controls brown fat cell differentiation and mitochondrial biogenesis. Sci Signal 2009 December 1;2(99):ra78.
(60) De TL, Strapazzon G, Gianesello L et al. Effects of type 5-phosphodiesterase inhibition on energy metabolism and mitochondrial biogenesis in human adipose tissue ex vivo. J Endocrinol Invest 2011 November;34(10):738-41.
(61) Lira VA, Brown DL, Lira AK et al. Nitric oxide and AMPK cooperatively regulate PGC-1 in skeletal muscle cells. J Physiol 2010 September 15;588(Pt 18):3551-66.
(62) Nisoli E, Tonello C, Cardile A et al. Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. Science 2005 October 14;310(5746):314-7.
(63) Suwa M, Nakano H, Radak Z, Kumagai S. Effects of Nitric Oxide Synthase Inhibition on Fiber-Type Composition, Mitochondrial Biogenesis, and SIRT1 Expression in Rat Skeletal Muscle. J Sports Sci Med 2015 September;14(3):548-55.
(64) Okazaki M, Iwasaki Y, Nishiyama M et al. PPARbeta/delta regulates the human SIRT1 gene transcription via Sp1. Endocr J 2010;57(5):403-13.
(65) Ren Y, Zheng J, Yao X, Weng G, Wu L. Essential role of the cGMP/PKG signaling pathway in regulating the proliferation and survival of human renal carcinoma cells. Int J Mol Med 2014 November;34(5):1430-8.
(66) Cen B, Deguchi A, Weinstein IB. Activation of protein kinase G Increases the expression of p21CIP1, p27KIP1, and histidine triad protein 1 through Sp1. Cancer Res 2008 July 1;68(13):5355-62.
(67) McCarty MF. Asymmetric Dimethylarginine Is a Well Established Mediating Risk Factor for Cardiovascular Morbidity and Mortality-Should Patients with Elevated Levels Be Supplemented with Citrulline? Healthcare (Basel) 2016 July 8;4(3).
(68) Antoniades C, Shirodaria C, Warrick N et al. 5-methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling. Circulation 2006 September 12;114(11):1193-201.
(69) Gao L, Siu KL, Chalupsky K et al. Role of uncoupled endothelial nitric oxide synthase in abdominal aortic aneurysm formation: treatment with folic acid. Hypertension 2012 January;59(1):158-66.
(70) Chalupsky K, Kracun D, Kanchev I, Bertram K, Gorlach A. Folic Acid Promotes Recycling of Tetrahydrobiopterin and Protects Against Hypoxia-Induced Pulmonary Hypertension by Recoupling Endothelial Nitric Oxide Synthase. Antioxid Redox Signal 2015 November 10;23(14):1076-91.
(71) Chen N, Leng YP, Xu WJ, Luo JD, Chen MS, Xiong Y. Contribution of endogenous inhibitor of nitric oxide synthase to hepatic mitochondrial dysfunction in streptozotocin-induced diabetic rats. Cell Physiol Biochem 2011;27(3-4):341-52.
(72) Villareal MO, Matsukawa T, Isoda H. L-Citrulline Supplementation-Increased Skeletal Muscle PGC-1alpha Expression is Associated With Exercise Performance and Increased Skeletal Muscle Weight. Mol Nutr Food Res 2018 May 24;e1701043.
(73) Valgas da Silva CP, Delbin MA, La Guardia PG et al. Improvement of the physical performance is associated with activation of NO/PGC-1alpha/mtTFA signaling pathway and increased protein expressions of electron transport chain in gastrocnemius muscle from rats supplemented with L-arginine. Life Sci 2015 March 15;125:63-70.
(74) Figueroa A, Wong A, Jaime SJ, Gonzales JU. Influence of L-citrulline and watermelon supplementation on vascular function and exercise performance. Curr Opin Clin Nutr Metab Care 2017 January;20(1):92-8.
(75) Follmann M, Griebenow N, Hahn MG et al. The chemistry and biology of soluble guanylate cyclase stimulators and activators. Angew Chem Int Ed Engl 2013 September 2;52(36):9442-62.
(76) Vesely DL. Biotin enhances guanylate cyclase activity. Science 1982 June 18;216(4552):1329-30.
(77) Vesely DL, Wormser HC, Abramson HN. Biotin analogs activate guanylate cyclase. Mol Cell Biochem 1984;60(2):109-14.
(78) McCarty MF, DiNicolantonio JJ. Neuroprotective potential of high-dose biotin. Med Hypotheses 2017 November;109:145-9.
(79) Watanabe-Kamiyama M, Kamiyama S, Horiuchi K et al. Antihypertensive effect of biotin in stroke-prone spontaneously hypertensive rats. Br J Nutr 2008 April;99(4):756-63.
(80) McCarty MF. Up-regulation of PPARgamma coactivator-1alpha as a strategy for preventing and reversing insulin resistance and obesity. Med Hypotheses 2005;64(2):399-407.
(81) Aguilera-Mendez A, Fernandez-Mejia C. The hypotriglyceridemic effect of biotin supplementation involves increased levels of cGMP and AMPK activation. Biofactors 2012 September;38(5):387-94.
(82) Boone-Villa D, Aguilera-Mendez A, Miranda-Cervantes A, Fernandez-Mejia C. Effects of Biotin Supplementation in the Diet on Adipose Tissue cGMP Concentrations, AMPK Activation, Lipolysis, and Serum-Free Fatty Acid Levels. J Med Food 2015 October;18(10):1150-6.
(83) Untereiner AA, Fu M, Modis K, Wang R, Ju Y, Wu L. Stimulatory effect of CSE-generated H2S on hepatic mitochondrial biogenesis and the underlying mechanisms. Nitric Oxide 2016 August 31;58:67-76.
(84) Shimizu Y, Polavarapu R, Eskla KL et al. Hydrogen sulfide regulates cardiac mitochondrial biogenesis via the activation of AMPK. J Mol Cell Cardiol 2018 March;116:29-40.
(85) Wu Y, Song P, Xu J, Zhang M, Zou MH. Activation of protein phosphatase 2A by palmitate inhibits AMP-activated protein kinase. J Biol Chem 2007 March 30;282(13):9777-88.
(86) Li S, Yang G. Hydrogen Sulfide Maintains Mitochondrial DNA Replication via Demethylation of TFAM. Antioxid Redox Signal 2015 September 1;23(7):630-42.
(87) Szabo C. Hydrogen sulfide, an enhancer of vascular nitric oxide signaling: mechanisms and implications. Am J Physiol Cell Physiol 2017 January 1;312(1):C3-C15.
(88) DiNicolantonio JJ, OKeefe JH, McCarty MF. Boosting endogenous production of vasoprotective hydrogen sulfide via supplementation with taurine and N-acetylcysteine: a novel way to promote cardiovascular health. Open Heart 2017;4(1):e000600.
(89) Sun Q, Wang B, Li Y et al. Taurine Supplementation Lowers Blood Pressure and Improves Vascular Function in Prehypertension: Randomized, Double-Blind, Placebo-Controlled Study. Hypertension 2016 March;67(3):541-9.
(90) Zhao H, Qu J, Li Q et al. Taurine supplementation reduces neuroinflammation and protects against white matter injury after intracerebral hemorrhage in rats. Amino Acids 2018 April;50(3-4):439-51.
(91) Borck PC, Vettorazzi JF, Branco RCS et al. Taurine supplementation induces long-term beneficial effects on glucose homeostasis in ob/ob mice. Amino Acids 2018 June;50(6):765-74.
(92) Cheong SH, Chang KJ. Antidiabetic effect of taurine in cultured rat skeletal l6 myotubes. Adv Exp Med Biol 2013;775:311-20.
(93) Kersten S. Integrated physiology and systems biology of PPARalpha. Mol Metab 2014 July;3(4):354-71.
(94) Botta M, Audano M, Sahebkar A, Sirtori CR, Mitro N, Ruscica M. PPAR Agonists and Metabolic Syndrome: An Established Role? Int J Mol Sci 2018 April 14;19(4).
(95) Tenenbaum A, Fisman EZ. Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction. Cardiovasc Diabetol 2012 October 11;11:125.
(96) Jia Y, Kim JY, Jun HJ et al. The natural carotenoid astaxanthin, a PPAR-alpha agonist and PPAR-gamma antagonist, reduces hepatic lipid accumulation by rewiring the transcriptome in lipid-loaded hepatocytes. Mol Nutr Food Res 2012 June;56(6):878-88.
(97) Jia Y, Wu C, Kim J, Kim B, Lee SJ. Astaxanthin reduces hepatic lipid accumulations in high-fat-fed C57BL/6J mice via activation of peroxisome proliferator-activated receptor (PPAR) alpha and inhibition of PPAR gamma and Akt. J Nutr Biochem 2016 February;28:9-18.
(98) Mashhadi NS, Zakerkish M, Mohammadiasl J, Zarei M, Mohammadshahi M, Haghighizadeh MH. Astaxanthin improves glucose metabolism and reduces blood pressure in patients with type 2 diabetes mellitus. Asia Pac J Clin Nutr 2018;27(2):341-6.
(99) Ikeuchi M, Koyama T, Takahashi J, Yazawa K. Effects of astaxanthin in obese mice fed a high-fat diet. Biosci Biotechnol Biochem 2007 April;71(4):893-9.
(100) Yoshida H, Yanai H, Ito K et al. Administration of natural astaxanthin increases serum HDL-cholesterol and adiponectin in subjects with mild hyperlipidemia. Atherosclerosis 2010 April;209(2):520-3.
(101) Choi HD, Youn YK, Shin WG. Positive effects of astaxanthin on lipid profiles and oxidative stress in overweight subjects. Plant Foods Hum Nutr 2011 November;66(4):363-9.
(102) Yang Y, Pham TX, Wegner CJ et al. Astaxanthin lowers plasma TAG concentrations and increases hepatic antioxidant gene expression in diet-induced obesity mice. Br J Nutr 2014 December 14;112(11):1797-804.
(103) Inagaki T, Dutchak P, Zhao G et al. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab 2007 June;5(6):415-25.
(104) Badman MK, Pissios P, Kennedy AR, Koukos G, Flier JS, Maratos-Flier E. Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab 2007 June;5(6):426-37.
(105) Lin Z, Tian H, Lam KS et al. Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice. Cell Metab 2013 May 7;17(5):779-89.
(106) Hui X, Feng T, Liu Q, Gao Y, Xu A. The FGF21-adiponectin axis in controlling energy and vascular homeostasis. J Mol Cell Biol 2016 April;8(2):110-9.
(107) Ong KL, Rye KA, O'Connell R et al. Long-term fenofibrate therapy increases fibroblast growth factor 21 and retinol-binding protein 4 in subjects with type 2 diabetes. J Clin Endocrinol Metab 2012 December;97(12):4701-8.
(108) Yamauchi T, Kamon J, Minokoshi Y et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002 November;8(11):1288-95.
(109) Tomas E, Tsao TS, Saha AK et al. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc Natl Acad Sci U S A 2002 December 10;99(25):16309-13.
(110) Wu X, Motoshima H, Mahadev K, Stalker TJ, Scalia R, Goldstein BJ. Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes. Diabetes 2003 June;52(6):1355-63.
(111) Liu PH, Aoi W, Takami M et al. The astaxanthin-induced improvement in lipid metabolism during exercise is mediated by a PGC-1alpha increase in skeletal muscle. J Clin Biochem Nutr 2014 March;54(2):86-9.
(112) Iwabu M, Yamauchi T, Okada-Iwabu M et al. Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1. Nature 2010 April 29;464(7293):1313-9.
(113) Qiao L, Kinney B, Yoo HS, Lee B, Schaack J, Shao J. Adiponectin increases skeletal muscle mitochondrial biogenesis by suppressing mitogen-activated protein kinase phosphatase-1. Diabetes 2012 June;61(6):1463-70.
(114) Wolf AM, Asoh S, Hiranuma H et al. Astaxanthin protects mitochondrial redox state and functional integrity against oxidative stress. J Nutr Biochem 2010 May;21(5):381-9.
(115) Kurashige M, Okimasu E, Inoue M, Utsumi K. Inhibition of oxidative injury of biological membranes by astaxanthin. Physiol Chem Phys Med NMR 1990;22(1):27-38.
(116) Zhang ZW, Xu XC, Liu T, Yuan S. Mitochondrion-Permeable Antioxidants to Treat ROS-Burst-Mediated Acute Diseases. Oxid Med Cell Longev 2016;2016:6859523.
(117) Tripathi DN, Jena GB. Astaxanthin intervention ameliorates cyclophosphamide-induced oxidative stress, DNA damage and early hepatocarcinogenesis in rat: role of Nrf2, p53, p38 and phase-II enzymes. Mutat Res 2010 February;696(1):69-80.
(118) Wu Q, Zhang XS, Wang HD et al. Astaxanthin activates nuclear factor erythroid-related factor 2 and the antioxidant responsive element (Nrf2-ARE) pathway in the brain after subarachnoid hemorrhage in rats and attenuates early brain injury. Mar Drugs 2014 December 18;12(12):6125-41.
(119) Xue XL, Han XD, Li Y et al. Astaxanthin attenuates total body irradiation-induced hematopoietic system injury in mice via inhibition of oxidative stress and apoptosis. Stem Cell Res Ther 2017 January 23;8(1):7.
(120) Zhu X, Chen Y, Chen Q, Yang H, Xie X. Astaxanthin Promotes Nrf2/ARE Signaling to Alleviate Renal Fibronectin and Collagen IV Accumulation in Diabetic Rats. J Diabetes Res 2018;2018:6730315.
(121) Feng Y, Chu A, Luo Q, Wu M, Shi X, Chen Y. The Protective Effect of Astaxanthin on Cognitive Function via Inhibition of Oxidative Stress and Inflammation in the Brains of Chronic T2DM Rats. Front Pharmacol 2018;9:748.
(122) Takaichi S, Matsui K, Nakamura M, Muramatsu M, Hanada S. Fatty acids of astaxanthin esters in krill determined by mild mass spectrometry. Comp Biochem Physiol B Biochem Mol Biol 2003 October;136(2):317-22.
(123) Aoi W, Maoka T, Abe R, Fujishita M, Tominaga K. Comparison of the effect of non-esterified and esterified astaxanthins on endurance performance in mice. J Clin Biochem Nutr 2018 March;62(2):161-6.
(124) Sethi S, Ziouzenkova O, Ni H, Wagner DD, Plutzky J, Mayadas TN. Oxidized omega-3 fatty acids in fish oil inhibit leukocyte-endothelial interactions through activation of PPAR alpha. Blood 2002 August 15;100(4):1340-6.
(125) Mishra A, Chaudhary A, Sethi S. Oxidized omega-3 fatty acids inhibit NF-kappaB activation via a PPARalpha-dependent pathway. Arterioscler Thromb Vasc Biol 2004 September;24(9):1621-7.
(126) Ashmore T, Roberts LD, Morash AJ et al. Nitrate enhances skeletal muscle fatty acid oxidation via a nitric oxide-cGMP-PPAR-mediated mechanism. BMC Biol 2015 December 22;13:110.
(127) Vaughan RA, Gannon NP, Carriker CR. Nitrate-containing beetroot enhances myocyte metabolism and mitochondrial content. J Tradit Complement Med 2016 January;6(1):17-22.
(128) Khan NA, Auranen M, Paetau I et al. Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3. EMBO Mol Med 2014 June;6(6):721-31.
(129) Cerutti R, Pirinen E, Lamperti C et al. NAD(+)-dependent activation of Sirt1 corrects the phenotype in a mouse model of mitochondrial disease. Cell Metab 2014 June 3;19(6):1042-9.
(130) Chowanadisai W, Bauerly KA, Tchaparian E, Wong A, Cortopassi GA, Rucker RB. Pyrroloquinoline quinone stimulates mitochondrial biogenesis through cAMP response element-binding protein phosphorylation and increased PGC-1alpha expression. J Biol Chem 2010 January 1;285(1):142-52.
(131) Saihara K, Kamikubo R, Ikemoto K, Uchida K, Akagawa M. Pyrroloquinoline Quinone, a Redox-Active o-Quinone, Stimulates Mitochondrial Biogenesis by Activating the SIRT1/PGC-1alpha Signaling Pathway. Biochemistry 2017 December 19;56(50):6615-25.
(132) Hwang P, Willoughby DS. Mechanisms Behind Pyrroloquinoline Quinone Supplementation on Skeletal Muscle Mitochondrial Biogenesis: Possible Synergistic Effects with Exercise. J Am Coll Nutr 2018 May 1;1-11.
(133) Lu J, Chen S, Shen M et al. Mitochondrial regulation by pyrroloquinoline quinone prevents rotenone-induced neurotoxicity in Parkinson's disease models. Neurosci Lett 2018 September 18;687:104-10.
(134) Remels AH, Gosker HR, Bakker J, Guttridge DC, Schols AM, Langen RC. Regulation of skeletal muscle oxidative phenotype by classical NF-kappaB signalling. Biochim Biophys Acta 2013 August;1832(8):1313-25.
(135) Patti ME, Butte AJ, Crunkhorn S et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A 2003 July 8;100(14):8466-71.
(136) Coll T, Jove M, Rodriguez-Calvo R et al. Palmitate-mediated downregulation of peroxisome proliferator-activated receptor-gamma coactivator 1alpha in skeletal muscle cells involves MEK1/2 and nuclear factor-kappaB activation. Diabetes 2006 October;55(10):2779-87.
(137) Richardson DK, Kashyap S, Bajaj M et al. Lipid infusion decreases the expression of nuclear encoded mitochondrial genes and increases the expression of extracellular matrix genes in human skeletal muscle. J Biol Chem 2005 March 18;280(11):10290-7.
(138) Remels AH, Gosker HR, Schrauwen P et al. TNF-alpha impairs regulation of muscle oxidative phenotype: implications for cachexia? FASEB J 2010 December;24(12):5052-62.
(139) Palomer X, Alvarez-Guardia D, Rodriguez-Calvo R et al. TNF-alpha reduces PGC-1alpha expression through NF-kappaB and p38 MAPK leading to increased glucose oxidation in a human cardiac cell model. Cardiovasc Res 2009 March 1;81(4):703-12.
(140) Alvarez-Guardia D, Palomer X, Coll T et al. The p65 subunit of NF-kappaB binds to PGC-1alpha, linking inflammation and metabolic disturbances in cardiac cells. Cardiovasc Res 2010 August 1;87(3):449-58.
(141) Patti ME, Butte AJ, Crunkhorn S et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A 2003 July 8;100(14):8466-71.
(142) Reyna SM, Ghosh S, Tantiwong P et al. Elevated toll-like receptor 4 expression and signaling in muscle from insulin-resistant subjects. Diabetes 2008 October;57(10):2595-602.
(143) Pal D, Dasgupta S, Kundu R et al. Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nat Med 2012 August;18(8):1279-85.
(144) McCarty MF, Assanga SBI. Ferulic acid may target MyD88-mediated pro-inflammatory signaling - Implications for the health protection afforded by whole grains, anthocyanins, and coffee. Med Hypotheses 2018 September;118:114-20.
(145) Ren Z, Zhang R, Li Y, Li Y, Yang Z, Yang H. Ferulic acid exerts neuroprotective effects against cerebral ischemia/reperfusion-induced injury via antioxidant and anti-apoptotic mechanisms in vitro and in vivo. Int J Mol Med 2017 November;40(5):1444-56.
(146) Gogoi B, Chatterjee P, Mukherjee S, Buragohain AK, Bhattacharya S, Dasgupta S. A polyphenol rescues lipid induced insulin resistance in skeletal muscle cells and adipocytes. Biochem Biophys Res Commun 2014 September 26;452(3):382-8.
(147) Dasgupta S, Bhattacharya S, Biswas A et al. NF-kappaB mediates lipid-induced fetuin-A expression in hepatocytes that impairs adipocyte function effecting insulin resistance. Biochem J 2010 August 1;429(3):451-62.
(148) Park HS, Jung HY, Park EY, Kim J, Lee WJ, Bae YS. Cutting edge: direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-kappa B. J Immunol 2004 September 15;173(6):3589-93.
(149) Menden HL, Xia S, Mabry SM, Navarro A, Nyp MF, Sampath V. Nicotinamide Adenine Dinucleotide Phosphate Oxidase 2 Regulates LPS-Induced Inflammation and Alveolar Remodeling in the Developing Lung. Am J Respir Cell Mol Biol 2016 December;55(6):767-78.
(150) Feng Y, Cui C, Liu X et al. Protective Role of Apocynin via Suppression of Neuronal Autophagy and TLR4/NF-kappaB Signaling Pathway in a Rat Model of Traumatic Brain Injury. Neurochem Res 2017 November;42(11):3296-309.
(151) Souto Padron de FA, Salmon AB, Bruno F et al. Nox2 mediates skeletal muscle insulin resistance induced by a high fat diet. J Biol Chem 2015 May 22;290(21):13427-39.
(152) McCarty MF. Clinical potential of Spirulina as a source of phycocyanobilin. J Med Food 2007 December;10(4):566-70.
(153) Zheng J, Inoguchi T, Sasaki S et al. Phycocyanin and phycocyanobilin from Spirulina platensis protect against diabetic nephropathy by inhibiting oxidative stress. Am J Physiol Regul Integr Comp Physiol 2013 January 15;304(2):R110-R120.
(154) Romay C, Gonzalez R, Ledon N, Remirez D, Rimbau V. C-phycocyanin: a biliprotein with antioxidant, anti-inflammatory and neuroprotective effects. Curr Protein Pept Sci 2003 June;4(3):207-16.
(155) Hernandez-Lepe MA, Lopez-Diaz JA, Juarez-Oropeza MA, Hernandez-Torres RP, Wall-Medrano A, Ramos-Jimenez A. Effect of Arthrospira (Spirulina) maxima Supplementation and a Systematic Physical Exercise Program on the Body Composition and Cardiorespiratory Fitness of Overweight or Obese Subjects: A Double-Blind, Randomized, and Crossover Controlled Trial. Mar Drugs 2018 October 1;16(10).

Most read articles by the same author(s)

Obs.: This plugin requires at least one statistics/report plugin to be enabled. If your statistics plugins provide more than one metric then please also select a main metric on the admin's site settings page and/or on the journal manager's settings pages.